TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck

Published:2001-05 Issue:2 Volume:59 Page:179-185
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Alsner Jan,Sørensen Susanne Berg,Overgaard Jens

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference37 articles.

1. High incidence of p53 alterations (mutation, deletion, over-expression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein over-expression in normal epithelium and in early non-invasive lesions;Ahomadegbe;Oncogene,1995

2. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck;Alsner;Int J Radiat Oncol Biol Phys,2001

3. The value of pre-treatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis;Begg;Radiother Oncol,1999

4. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers;Bjørk-Eriksson;Int J Radiat Oncol Biol Phys,2000

5. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases;Blencowe;Trends Biochem Sci,2000

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer;Frontiers in Oncology;2023-03-29

2. Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells;Biomolecules;2023-02-07

3. Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysis;Scientific Reports;2022-12-01

4. Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysis;2022-09-20

5. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma;JNCI: Journal of the National Cancer Institute;2022-09-02